Association of a F479L variant in the cytosolic phospholipase A2 gene (PLA2G4A) with decreased glucose turnover and oxidation rates in Pima Indians

Molecular Genetics and Metabolism

Volumn 79, Issue 1, 2003, Pages 61-66

  Wolford, Johanna K ^a   Konheim, Yasmine L ^a   Colligan, Peter B ^a   Bogardus, Clifton ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Arachidonic acid; Candidate gene analysis; Chromosome 1q; Glucose oxidation; Lipid oxidation; Single nucleotide polymorphisms (SNPs); Type 2 diabetes mellitus

Indexed keywords

ARACHIDONIC ACID; GLUCOSE; ICOSANOID; INSULIN; LEUCINE; PHENYLALANINE; PHOSPHOLIPASE A2;

ARTICLE; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCATION; GENETIC LINKAGE; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; GLUCOSE METABOLISM; GLUCOSE OXIDATION; HUMAN; INDIAN; INSULIN RELEASE; LIPID OXIDATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

EID: 0037508502     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-7192(03)00051-9     Document Type: Article

References (42)

1. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
2. DeFronzo R.A. Lilly lecture 1987. The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 37:1988;667-687.
3. Hanson R.L., Elston R.C., Pettitt D.J., Bennett P.H., Knowler W.C. Segregation analysis of non-insulin-dependent diabetes mellitus in Pima Indians: evidence for a major-gene effect. Am. J. Hum. Genet. 57:1995;160-170.
4. Hanson R.L., Ehm M.G., Pettitt D.J., Prochazka M., Thompson D.B., Timberlake D., Foroud T., Kobes S., Baier L., Burns D.K., Almasy L., Blangero J., Garvey W.T., Bennett P.H., Knowler W.C. An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am. J. Hum. Genet. 63:1998;1130-1138.
5. Elbein S.C., Hoffman M.D., Teng K., Leppert M.F., Hasstedt S.J. A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes. 48:1999;1175-1182.
6. Vionnet N., Hani E., Dupont S., Gallina S., Francke S., Dotte S., De Matos F., Durand E., Lepretre F., Lecoeur C., Gallina P., Zekiri L., Dina C., Froguel P. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am. J. Hum. Genet. 67:2000;1470-1480.
7. Wiltshire S., Hattersley A.T., Hitman G.A., Walker M., Levy J.C., Sampson M., O'Rahilly S., Frayling T.M., Bell J.I., Lathrop G.M., Bennett A., Dhillon R., Fletcher C., Groves C.J., Jones E., Prestwich P., Simecek N., Rao P.V., Wishart M., Bottazzo G.F., Foxon R., Howell S., Smedley D., Cardon L.R., Menzel S., McCarthy M.I. A genomewide scan for loci predisposing to type 2 diabetes in a UK population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am. J. Hum. Genet. 69:2001;553-569.
8. Hsueh W.C., St Jean P.L., Mitchell B.D., Pollin T.I., Knowler W.C., Ehm M.G., Bell C.J., Sakul H., Wagner M.J., Burns D.K., Shuldiner A.R. Genome-wide and fine-mapping linkage studies of type 2 diabetes and glucose traits in the old order amish: evidence for a new diabetes locus on chromosome 14q11 and confirmation of a locus on chromosome 1q21-q24. Diabetes. 52:2003;550-557.
9. Xiang K. Search for type 2 diabetes susceptibility genes in Chinese. (Abstract) Diabetes Res. Clin. Pract. 56(Suppl.1):2002;S8.
10. Qiu Z.H., Gijon M.A., de Carvalho M.S., Spencer D.M., Leslie C.C. The role of calcium and phosphorylation of cytosolic phospholipase A2 in regulating arachidonic acid release in macrophages. J. Biol. Chem. 273:1998;8203-8211.
11. Clark J.D., Lin L.L., Kriz R.W., Ramesha C.S., Sultzman L.A., Lin A.Y., Milona N., Knopf J.L. A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell. 65:1991;1043-1051.
12. Parker K.J., Jones P.M., Hunton C.H., Persaud S.J., Taylor C.G., Howell S.L. Identification and localisation of a type IV cytosolic phospholipase A2 in rat pancreatic β-cells. J. Mol. Endocrinol. 17:1996;31-43.
13. Chen M., Yang Z., Naji A., Wolf B.A. Identification of calcium-dependent phospholipase A2 isoforms in human and rat pancreatic islets and insulin secreting β-cell lines. Endocrinology. 137:1996;2901-2909.
14. Ahren B., Magrum L.J., Havel P.J., Greene S.F., Phinney S.D., Johnson P.R., Stern J.S. Augmented insulinotropic action of arachidonic acid through the lipoxygenase pathway in the obese Zucker rat. Obes. Res. 8:2000;475-480.
15. Hwang I.K., Go V.L., Harris D.M., Yip I., Song M.K. Effects of arachidonic acid plus zinc on glucose disposal in genetically diabetic (ob/ob) mice. Diabetes Obes. Metab. 4:2002;124-131.
16. Tebbey P.W., McGowan K.M., Stephens J.M., Buttke T.M., Pekala P.H. Arachidonic acid down-regulates the insulin-dependent glucose transporter gene (GLUT4) in 3T3-L1 adipocytes by inhibiting transcription and enhancing mRNA turnover. J. Biol. Chem. 269:1994;639-644.
17. Fong J.C., Chen C.C., Liu D., Chai S.P., Tu M.S., Chu K.Y. Arachidonic acid stimulates the intrinsic activity of ubiquitous glucose transporter (GLUT1) in 3T3-L1 adipocytes by a protein kinase C-independent mechanism. Cell Signal. 8:1996;179-183.
18. Grunfeld C., Baird K.L., Kahn C.R. Maintenance of 3T3-L1 cells in culture media containing saturated fatty acids decreases insulin binding and insulin action. Biochem. Biophys. Res. Commun. 103:1981;219-226.
19. Nugent C., Prins J.B., Whitehead J.P., Wentworth J.M., Chatterjee V.K., O'Rahilly S. Arachidonic acid stimulates glucose uptake in 3T3-L1 adipocytes by increasing GLUT1 and GLUT4 levels at the plasma membrane. Evidence for involvement of lipoxygenase metabolites and peroxisome proliferator-activated receptor γ J. Biol. Chem. 276:2001;9149-9157.
20. Forman B.M., Chen J., Evans R.M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ Proc. Natl. Acad. Sci. USA. 94:1997;4312-4317.
21. Kliewer S.A., Sundseth S.S., Jones S.A., Brown P.J., Wisely G.B., Koble C.S., Devchand P., Wahli W., Willson T.M., Lenhard J.M., Lehmann J.M. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ Proc. Natl. Acad. Sci. USA. 94:1997;4318-4323.
22. Krey G., Braissant O., L'Horset F., Kalkhoven E., Perroud M., Parker M.G., Wahli W. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11:1997;779-791.
23. Xu H.E., Lambert M.H., Montana V.G., Parks D.J., Blanchard S.G., Brown P.J., Sternbach D.D., Lehmann J.M., Wisely G.B., Willson T.M., Kliewer S.A., Milburn M.V. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol. Cell. 3:1999;397-403.
24. Kliewer S.A., Lenhard J.M., Willson T.M., Patel I., Morris D.C., Lehmann J.M. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell. 83:1995;813-819.
25. H. Ma, H.W. Sprecher, P.E. Kolattukudy, Estrogen-induced production of a peroxisome proliferator-activated receptor (PPAR) ligand in a PPARgamma-expressing tissue. 273 (1998) 30131-30138.
26. Yu K., Bayona W., Kallen C.B., Harding H.P., Ravera C.P., McMahon G., Brown M., Lazar M.A. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem. 270:1995;23975-23983.
27. Auwerx J. PPARγ, the ultimate thrifty gene. Diabetologia. 42:1999;1033-1049.
28. Willson T.M., Brown P.J., Sternbach D.D., Henke B.R. The PPARs: from orphan receptors to drug discovery. J. Med. Chem. 43:2000;527-550.
29. Knowler W.C., Bennett P.H., Hamman R.F., Miller M. Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am. J. Epidemiol. 108:1978;497-505.
30. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetes Med. 15:1998;539-553.
31. Wolford J.K., Blunt D., Ballecer C., Prochazka M. High-throughput SNP detection by using DNA pooling and denaturing high performance liquid chromatography (DHPLC). Hum. Genet. 107:2000;483-487.
32. Lillioja S., Mott D.M., Howard B.V., Bennett P.H., Yki-Jarvinen H., Freymond D., Nyomba B.L., Zurlo F., Swinburn B., Bogardus C. Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N. Engl. J. Med. 318:1988;1217-1225.
33. Weyer C., Bogardus C., Pratley R.E. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes. 48:1999;2197-2203.
34. Bogardus C., Lillioja S., Ravussin E., Abbott W., Zawadzki J.K., Young A., Knowler W.C., Jacobowitz R., Moll P.P. Familial dependence of the resting metabolic rate. N. Engl. J. Med. 315:1986;96-100.
35. Zeger S.L., Liang K.Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 42:1986;121-130.
36. Lillioja S., Mott D.M., Spraul M., Ferraro R., Foley J.E., Ravussin E., Knowler W.C., Bennett P.H., Bogardus C. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N. Engl. J. Med. 329:1993;1988-1992.
37. Han C., Demetris A.J., Michalopoulos G., Shelhamer J.H., Wu T. 85-kDa cPLA(2) plays a critical role in PPAR-mediated gene transcription in human hepatoma cells. Am. J. Physiol. Gastrointest. Liver Physiol. 282:2002;G586-G597.
38. Shimaya A., Kurosaki E., Shioduka K., Nakano R., Shibasaki M., Shikama H. YM268 increases the glucose uptake, cell differentiation, and mRNA expression of glucose transporter in 3T3-L1 adipocytes. Horm. Metab. Res. 30:1998;543-548.
39. Day C. Thiazolidinediones: a new class of antidiabetic drugs. Diabetes Med. 16:1999;179-192.
40. Nugent C., Prins J.B., Whitehead J.P., Savage D., Wentworth J.M., Chatterjee V.K., O'Rahilly S. Potentiation of glucose uptake in 3T3-L1 adipocytes by PPARγ agonists is maintained in cells expressing a PPARγ dominant-negative mutant: evidence for selectivity in the downstream responses to PPARγ activation. Mol. Endocrinol. 15:2001;1729-1738.
41. Wolford J.K., Hanson R.L., Kobes S., Bogardus C., Prochazka M. Analysis of linkage disequilibrium between polymorphisms in the KCNJ9 gene with type 2 diabetes mellitus in Pima Indians. Mol. Genet. Metab. 73:2001;97-103.
42. Wolford J.K., Gruber J.D., Ossowski V.M., Vozarova B., Antonio T.P., Bogardus C., Hanson R.L. A C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians. Mol. Genet. Metab. 78:2003;136-144.